Human neutrophil elastase is an important regulator of the immune response and plays a role in host defense mechanisms and further physiological processes. The uncontrolled activity of this serine protease may cause severe tissue alterations and impair inflammatory states. The design of an activity-based probe for human neutrophil elastase reported herein relies on a sulfonyloxyphthalimide moiety as a new type of warhead which was linker-connected to a coumarin fluorophore. The inhibitory potency of the activity-based probe was assessed against several serine and cysteine proteases and selectivity for human neutrophil elastase (K i = 6.85 nM) was determined. The adequate fluorescent tag of the probe allowed for the in-gel fluorescence detection of human neutrophil elastase in the low nanomolar range. The coumarin moiety and the anthranilic acid function of the probe, produced in the course of a Lossen rearrangement, were part of two different Förster resonance energy transfers.
INTRODUCTION Human neutrophil elastase (HNE) belongs to the chymotrypsin family of serine proteases and is primarily localized in the azurophilic granules and released upon stimulation of the polymorphonuclear neutrophils. HNE has a shallow S1 pocket resulting in a primary substrate specificity for small aliphatic residues, e.g. of alanine, isoleucine or valine, in the P1 position of the substrate. As a serine protease, HNE cleaves its substrates following an acyl transfer mechanism.
1 HNE exhibits a broad substrate specificity. It cleaves fibrous elastin, a highly elastic protein in connective tissues, as well as fibronectin, laminin and collagens. Besides these extracellular matrix proteins, HNE degrades a variety of plasma proteins, activates other proteases or deactivates their endogenous inhibitors and liberates growth factors. 1 HNE participates in host defense against microbial pathogens due to its capability of cleaving outer membrane proteins of Gram-negative bacteria. A fusion of azurophilic granules with vacuoles carrying phagocytosed bacteria leads to the formation of phagolysosomes, the site of pathogen clearance. 1 In addition to intracellular defense mechanisms, HNE exerts an extracellular antimicrobial activity. It serves as a component of the neutrophil extracellular traps, a network of chromatin and granule proteins, which is actively secreted by neutrophils. 1, 2 In pathophysiological conditions, a deleterious effect may result from the extended tissue destruction catalyzed by HNE. Upon neutrophil activation at inflammatory sites, HNE is abundantly released into the intercellular space, thereby activating proinflammatory mediators and recruiting further neutrophils. Thus, the out-of-balance activity of HNE contributes to the onset and progression of several inflammatory disorders, among them chronic obstructive pulmonary disease, respiratory distress syndrome (ARDS), acute lung injury (ALI), cystic fibrosis and rheumatoid arthritis. Biochemistry   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   5 Upon neutrophil activation by cytokines, chemoattractants or bacterial lipopolysaccharides, HNE is secreted into the extracellular space, and a fraction of the proteolytically active enzyme remains associated with the outer surface of the plasma membrane of neutrophils. In particular, the lipid leukotriene B 4 (LTB 4 ) is known to efficiently induce both cell surface presentation of HNE and HNE release into the environment. The activation of the LTB 4 -HNE axis can promote the cleavage of adhesion molecules and drive remote organ damage.
3
Potent and selective HNE inhibitors could prove therapeutically useful to reduce or treat HNEdependent disorders. Sivelestat has reached the market for the treatment of ALI/ARDS in Japan and South Korea. Sivelestat has been reported to interact with HNE in a substrate-like manner.
The drug's ester bond undergoes an enzymatic cleavage, a pivaloyl residue is transferred to the active site serine and the resulting acyl enzyme is proposed to undergo hydrolysis. 4 Other inhibitors of HNE comprise, e.g. peptidic trifluoromethyl ketones and phosphonates, 5 4H-3,1-benzoxazin-ones, 6 azetidine-2,4-diones and saccharines, 7 kojic acid derivatives, 8 cyanobacterial cyclic peptides and depsipeptides. 9 Several classes of structurally-diverse heterocyclic HNE inhibitors, including 2-pyridones (e.g. AZD9668) and 3,4-dihydropyrimidin-2(1H)-ones (e.g.
BAY-678), have been reported. 1 Due to the protease's involvement in several diseases and its role as a pathogenic mediator in pulmonary disorders, HNE inhibition has become an important pharmaceutical option. Aside its role as a drug target, HNE-generated fragments of elastin and, recently, HNE itself have been described to be biomarkers for certain elastase-related conditions. 10 Moreover, activity-based probes (ABPs) for HNE are considered to be valuable for the detection and detailed investigation of this protease. In general, ABPs for serine proteases have emerged as powerful tools in life science. 11 ABPs enlarge the repertoire of methods, of which Western blotting is particularly Biochemistry   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 
MATERIALS AND METHODS

General.
Melting points were determined on a Büchi 50 oil bath apparatus. Thin layer chromatography was performed using Merck aluminium sheets coated with silica gel 60 F 254 .
NMR spectra were recorded using Bruker Avance III-600 MHz and Bruker Avance DRX-500
MHz instruments. LC-DAD chromatograms and ESI-MS spectra were recorded on an Agilent 1100 HPLC system with an Applied Biosystems API-2000 mass spectrometer. HRMS was performed on a microTOF-Q mass spectrometer (Bruker, Köln, Germany) with ESI-source coupled with a HPLC Dionex Ultimate 3000 (Thermo Scientific, Braunschweig, Germany) using a EC50/2 Nucleodur C18 Gracity 3 µm column (Macherey-Nagel, Düren, Germany). A volume of one µL of a sample solution (1.0 mg/mL) was injected. Mobile phase was a mixture of 2 mM aqueous ammonium acetate solution and acetonitrile. Elution was performed from 90:10 up to 0:100 in 9 min, 0:100 for 5 min. Elemental analysis was performed with a vario MICRO Biochemistry   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 Biochemistry   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 8 Human Thrombin. 21 Assay buffer was 50 mM Tris-HCl containing 150 mM NaCl, pH 8.0.
The enzyme stock solution (10000 U/mL) was prepared in water, diluted with assay buffer and kept at 0°C. A 10 mM stock solution of the fluorogenic substrate Z-Gly-Gly-Arg-AMC in Human Cathepsin L. 24 Assay buffer was 100 mM sodium phosphate buffer containing 100 mM NaCl, 5 mM EDTA and 0. A photomultiplier tube (PMT) value of 300 V was adjusted. The experiments were performed at 25°C for 60 min. Buffer was 50 mM sodium phosphate buffer and 500 mM NaCl, pH 7.8. A PPE solution was prepared in 10 mM sodium acetate buffer, pH 5.5. Probe 8 was dissolved DMSO.
The final concentration of PPE was 3.1 U/mL and the final concentration of DMSO was 1.5%.
Buffer, DMSO and probe 8 were placed in a cuvette. It was thoroughly mixed and the reaction was initiated by adding the enzyme. Experiments were performed in duplicate with five different inhibitor concentrations.
λ ex 285 nm FRET. The experiments were performed as described above with the following exception. The reactions of 8 with PPE were followed over 60 min or 8 hours by monitoring a possible FRET from a tryptophan fluorophore of PPE to the coumarin 343 by setting the excitation wavelength for tryptophan at λ ex = 285 nm and the emission wavelength of coumarin 343 at λ em = 492 nm.
Detection of Human Neutrophil Elastase with the Activity-based Probe 8. Estimation of the Detection Limit of the Probe.
A 200 µM solution of the activity-based probe 8 was prepared in DMSO. A HNE solution of 267 µg/mL was prepared in 100 mM sodium acetate buffer, pH 5.5. Elastase assay buffer (50 mM sodium phosphate buffer containing 500 mM NaCl, pH 7.8) was used to prepare mixtures of a total volume of 40 µL containing 2.5 µM of probe 8, 2.5%
DMSO and different concentration of HNE (11 ng/µL, 18 ng/µL, 25 ng/µL, 33 ng/µL, 40 ng/µL) ( Fig. 5A ). These mixtures were incubated at 25 °C for 20 min. To 18 µL of each mixture, 6 µL of reducing 4× Roti-Load 1 buffer (Roth, Karlsruhe, Germany) was added followed by heating at 95 °C for 5 min. After centrifugation (14,000 × g, 5 min), volumes of 20 µL were loaded and proteins were separated by SDS-PAGE. Gels (13%) were run in Tris/glycine/SDS buffer (Tris 25 mM, glycine 192 mM, SDS 0.1%). The enzyme was visualized by in-gel fluorescence detection using a Typhoon Trio scanner (GE Healthcare) and applying a setting which is most adequate for Detection of endogenous HNE. Human granulocytes were isolated from peripheral blood of healthy donors using density gradient centrifugation (Histopaque, Sigma Aldrich). For the preparation of the cell lysates, purified granulocytes (40 mio cells) were lysed in 100 µL of lysis buffer (1% Triton X-100 in phosphate buffer saline, pH 7.4). Cell debris was removed by 
RESULTS AND DISCUSSION
Sulfonyloxyphthalimides have been reported as efficient inactivators for HNE and other serine proteases. [26] [27] [28] According to the mechanism depicted in Scheme 1, 26 the protease-inhibitor interaction involves a nucleophilic attack of the active-site serine residue at the carbonyl carbon leading to an opening of the heterocyclic ring and a subsequent Lossen rearrangement of the Osulfonyl hydroxamic acid intermediate. 26, 29, 30 If the resulting isocyanate is trapped by water, the acyl enzyme undergoes slow hydrolysis and the enzymatic activity might be recovered. The isocyanate can alternatively react with a second, adjacent nucleophile from the protein matrix, e.g. with His-57 of HNE. In fact, the efficacy of such enzyme-activated inhibitors relies on the initially formed acyl enzyme, which keeps the isocyanate tethered at the active site and facilitates a second covalent attachment, leading to irreversible inactivation. This Lossen-based reactivity of low-molecular weight compounds bearing the cyclic CO-N(OSO 2 Alk)-CO motif towards 
For the design of a new type of activity-based probes for HNE, we considered the formation of anthranilic acid derivatives (Scheme 1) in the course of the enzyme-inhibitor interaction. In order to devise a possible FRET sequence from the protein's tryptophan residues via anthranilic acid to a suitable fluorescent reporter, we decided to incorporate coumarin 343 into the ABP for HNE.
Coumarins with donor groups at the position 7, such as coumarin 343, represent a widely used We aimed at synthesizing a small series of linker-connected N-(mesyloxy)phthalimides (Scheme 2). The nitro-substituted N-hydroxyphthalimide 1 was chosen as the starting compound whose nitro group was reduced using Pd/C to afford compound 2. This was converted into a sodium salt with NaHCO 3 and immediately reacted with methanesulfonyl chloride to obtain 3. Biochemistry   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 Compound 8 was investigated as an inhibitor of HNE by means of a spectroscopic assay with the chromogenic substrate MeOSuc-Ala-Ala-Pro-Val-pNA (Table 1) . Additionally, an estimation of the bioactivity of the Boc-protected building blocks 5a-d was carried out. These compounds showed time-dependent inhibition and the progress curves were analyzed with the slow-binding equation, implementing a distinct steady-state rate. From the first-order rate constants and the steady-rate rates, second-order rate constants for the formation of enzyme-inhibitor complexes, k on , and K i values, respectively, were obtained. The corresponding analysis for the HNE inhibition by probe 8 is depicted in Figure 1 . The first-order rate constants for the decay of the enzyme-inhibitor complexes, k off , were calculated from k on and K i values ( Table 1 Table 1 .
ABP 8 was further evaluated using different serine and cysteine proteases, all of which are characterized by a covalent mode of catalysis. For this purpose, activity assays with chromogenic or fluorogenic peptide substrates were applied (Table 2) Biochemistry   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 cathepsin L as well as the bovine enzymes chymotrypsin, factor Xa and trypsin. In contrast, time-dependent inactivation was observed for HNE (see above) and porcine pancreatic elastase (PPE). In order to quote comparable values, half maximal inhibitory concentrations, corrected by the substrate concentration, are given in Table 2 . These data indicate the strong preference of ABP 8 to inhibit the target enzyme HNE. (Fig. 2) . The spectra of 8 exhibited slight bathochromic shifts for both absorption maxima and emission maxima with increasing polarity of the solvent and Stokes shifts between 34-44 nm. Thus, due to the properties of the coumarin 343 moiety, probe 8 appears to be qualified to act as the final fluorescence acceptor in FRET systems. To exploit a first FRET system, excessive PPE was incubated with ABP 8 at different concentrations and the reaction was followed over 60 min. Data of the first 33 min are shown in (9) which represents the covalently inhibited enzyme species. The consumption of 8 in this Lossen-type conversion is irreversible, but a fraction of the protease can recover its activity when 9 undergoes hydrolysis and the product of the enzyme-catalyzed conversion (10) is released. ? a A supposed λ ex 285 nm FRET between the enzyme's tryptophan (excitation 285 nm) and coumarin 343 (emission 490 nm). A λ ex 320 nm FRET between the anthranilic acid moiety (excitation 320 nm) and coumarin 343 (emission 490 nm).
Next, it was intended to comprise the tryptophan fluorescence of PPE. For the generation of a FRET signal, there are two tryptophan residues in a sufficient distance to the active site. 36 These distances of about 11-12 Å were estimated by building a model of a covalent complex, see
Supporting Information (SI, Fig. S1 ). For this purpose, we have modeled the active site of PPE Biochemistry   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   26 with the catalytic serine residue bound to an unsubstituted anthranoyl residue, representing a simplified model of complex 9 (Scheme 3). The phenyl ring of the resulting Ser195-anthranilic acid ester complex acts as a fluorophore that can be excited by the nearby tryptophan moieties.
The following FRET kinetic experiments have been designed to include the excitation of tryptophan at 285 nm, which, in turn, might excite the anthranilic acid fluorophore, leading to the excitation of the coumarin moiety and the emission at 490 nm (Scheme 3). Except of the excitation wavelength, the λ ex 285 nm FRET experiment was performed under the same conditions as described above. We monitored a strong increase in fluorescence intensity within the first 15 min, which expectedly depended on the initial concentration of the probe 8 (Fig. 4A) .
A slow decrease in fluorescence intensity at the later stage of the reaction was observed.
Accordingly, an equation for the non-linear regression of the progress curves was used which includes final slopes different from zero. The pseudo-first order kinetics was confirmed also for this process by demonstrating the linear correlation between the initial rates and the concentrations of probe 8 as shown in the corresponding secondary plot (Fig. 4B ).
The λ ex 285 nm FRET setup provided experimental support for the formation of an enzymeprobe complex which contains the anthranilic acid fluorophore (i.e. complex 9, Scheme 3). The modified probe 10 was probably not recorded due to the interruption of the FRET system when complex 9 dissociated. Thus, the slow hydrolytic cleavage of 9 was supposed to account for the late decrease of the fluorescence signal. In a separate experiment, fluorescence kinetics was Biochemistry   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 producing the λ ex 285 nm FRET was estimated to be 3.3 hours. This value, obtained by fluorescence kinetics with PPE, is in the same range as the half-live of 71 min as obtained from inhibition kinetics with HNE. The difference is assumed to be mainly due to the origin of the enzyme in both experiments. The decay of this complex 9 indicates the involvement of tryptophan residue(s) in the first energy transfer step. These assumption is furthermore supported by afore-described inhibition kinetics with mesyloxyphthalimides which showed steady-state rates different from zero, again reflecting a slow release of the ring-opened probe and the simultaneous recovery of the protease. However, further experimental evidence is needed to clarify the involvement of tryptophan(s) in the λ ex 285 nm FRET system. For example, in future studies, the FRET efficiency might be examined with the enzyme mutated on the two tryptophan residues in proximity to the active site.
The suitability of compound 8 as an activity-based probe was proved by in-gel fluorescence analysis of HNE (Fig. 5 ). HNE at different concentrations was treated with 2.5 µM of 8 for 20
min. Following SDS-PAGE, fluorescent bands at approximately 29 kDa could be detected and amounts as low as 160 ng of HNE successfully visualized (lanes 1-5 in Fig. 5A ). Three bands were observed for HNE (e.g. lane 2 in Fig. 5B , lane 2-3 in Fig. 5C ). It is known that several HNE isoforms can be resolved by SDS-PAGE and that these catalytically active forms only differ in their carbohydrate content. Moreover, the self-cleavage of elastase from murine and human neutrophils was shown to generate variants of different catalytic activity. 37 Since elastase used in our study was prepared from human neutrophils, we assume that the three bands correspond to HNE isoforms with different glycosylation patterns or are caused by autocatalytic cleavage.
The binding mode of probe 8 in the active site of HNE was verified by a competition experiment (Fig. 5B) . HNE was incubated for 5 min with 5 µM of the active-site directed, Biochemistry   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 covalent inhibitor sivelestat, 4 followed by 2.5 µM of ABP 8 (lane 1 in Fig. 5B ). In the control experiment, HNE was incubated with DMSO prior to the addition of the probe (lane 2 in Fig.   5B ). Sivelestat was able to protect HNE from a reaction with the probe as the detectable fluorescence at ∼29 kDa was strongly reduced. These findings confirmed the active-site directed interaction of 8 with HNE and indicated that surface nucleophiles of the enzyme were obviously not affected by probe 8.
Furthermore, the selectivity of HNE labeling by 8 was studied as illustrated in Figures 5C and   5D . HEK293 cell lysate was spiked with HNE, incubated with the probe, subjected to SDS-PAGE and analyzed by fluorescence imaging. In contrast to the imaging of 600 ng of HNE (lane 2 in Fig. 5C ), amounts of 9 µg HEK cell lysate protein did not produce fluorescent bands (lane 1 in Fig. 5C ), indicating that 8 did not react with non-target proteins. As a control, the gel was subsequently stained with Coomassie blue (lanes 1 and 2 in Fig. 5D ). We performed two spiking experiments (lanes 3 and 4 in Figures 5C and 5D ). HEK lysate was added either after the incubation to the mixture of HNE and 8, or prior to the incubation. When HNE was incubated with 8 only, the protease has been inactivated due to reaction with 8 and, thus, became unable to degrade the lysate's proteins. Therefore, the Coomassie staining of the protein mixtures in lanes 1 and 3 (Fig. 5D ) was similar. However, when HNE was simultaneously incubated with the lysate and 8, protein degradation occurred and the enzyme was partly protected from being inactivated by 8 due to the consumption of protein substrates. This led to a different protein pattern (lane 4 versus lane 3 in Fig. 5D ) and to a slightly reduced intensity of the fluorescent signal of HNE (lane 4 versus lane 3 in Fig. 5C ). Importantly, this analysis revealed selective labeling of the target HNE within a mixture of excess proteins without detectable nonspecific interactions of 8 (lanes 3 and 4 in Fig. 5C ). Therefore, in the course of this study, we thought to assess the suitability of ABP 8 for detecting endogenous elastase. For this purpose, neutrophil granulocytes from human donors were purified by density gradient centrifugation and lysates were prepared by detergent (Triton X-100) treatment. The following analysis by gel electrophoresis of the lysate proteome revealed a fluorescent band at ∼29 kDa which could clearly be assigned to HNE (lane 3 in Fig. 6A ). In the competition experiment, it was shown, that the addition of sivelestat prior to the probe 8 was able
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